|
1
|
Australia Institute Health Welfare, .
Cancer in Australia 2019. Cancer Series no 119. 2019.
|
|
2
|
Australian Institute of Health Welfare, .
Cancer in Australia: Actual incidence data from 1982 to 2013 and
mortality data from 1982 to 2014 with projections to 2017. Asia Pac
J Clin Oncol. 14:5–15. 2018. View Article : Google Scholar
|
|
3
|
Whiteman DC, Webb PM, Green AC, Neale RE,
Fritschi L, Bain CJ, Parkin DM, Wilson LF, Olsen CM, Nagle CM, et
al: Cancers in Australia in 2010 attributable to modifiable
factors: Summary and conclusions. Aust N Z J Public Health.
39:477–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feletto E, Bang A, Cole-Clark D, Chalasani
V, Rasiah K and Smith DP: An examination of prostate cancer trends
in Australia, England, Canada and USA: Is the Australian death rate
too high? World J Urol. 33:1677–1687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feletto E, Yu XQ, Lew JB, St John DJB,
Jenkins MA, Macrae FA, Mahady SE and Canfell K: Trends in colon and
rectal cancer incidence in Australia from 1982 to 2014: Analysis of
data on over 375,000 cases. Cancer Epidemiol Biomarkers Prev.
28:83–90. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Z, Zhao S, Liu Y, Wang J, Luo L, Li E,
Zhang C, Luo J and Zhao Z: Risk of secondary rectal cancer and
colon cancer after radiotherapy for prostate cancer: A
meta-analysis. Int J Colorectal Dis. 33:1149–1158. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Margel D, Baniel J, Wasserberg N,
Bar-Chana M and Yossepowitch O: Radiation therapy for prostate
cancer increases the risk of subsequent rectal cancer. Ann Surg.
254:947–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wallis CJ, Mahar AL, Choo R, Herschorn S,
Kodama RT, Shah PS, Danjoux C, Narod SA and Nam RK: Second
malignancies after radiotherapy for prostate cancer: Systematic
review and meta-analysis. BMJ. 352:i8512016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Desautels D, Czaykowski P, Nugent Z,
Demers AA, Mahmud SM and Singh H: Risk of colorectal cancer after
the diagnosis of prostate cancer: A population-based study. Cancer.
122:1254–1260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee YC, Hsieh CC, Li CY, Chuang JP and Lee
JC: Secondary cancers after radiation therapy for primary prostate
or rectal cancer. World J Surg. 40:895–905. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rombouts AJM, Hugen N, Elferink MAG, Feuth
T, Poortmans PMP, Nagtegaal ID and de Wilt JHW: Incidence of second
tumors after treatment with or without radiation for rectal cancer.
Ann Oncol. 28:535–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chuang JP, Lee YC, Lee JC, Lu CL and Li
CY: A Population-Based study of secondary prostate cancer risk
after radiotherapy in male patients with rectal cancer: A
retrospective cohort study. Medicina (Kaunas). 55:1042019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martling A, Smedby KE, Birgisson H, Olsson
H, Granath F, Ekbom A and Glimelius B: Risk of second primary
cancer in patients treated with radiotherapy for rectal cancer. Br
J Surg. 104:278–287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feinberg AE, Wallis CJD, Nam RK and Hameed
U: Survival and peri-operative outcomes among patients with rectal
cancer: The role of prior radiotherapy due to prostate cancer. Int
J Colorectal Dis. 34:97–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rahbari NN, Elbers H, Askoxylakis V,
Motschall E, Bork U, Büchler MW, Weitz J and Koch M: Neoadjuvant
radiotherapy for rectal cancer: Meta-analysis of randomized
controlled trials. Ann Surg Oncol. 20:4169–4182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lim MC, Won YJ, Lim J, Seo SS, Kang S, Yoo
CW, Kim JY, Oh JH, Bristow RE and Park SY: Second primary
colorectal cancer among endometrial cancer survivor: Shared
etiology and treatment sequelae. J Cancer Res Clin Oncol.
144:845–854. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weinberg DS, Newschaffer CJ and Topham A:
Risk for colorectal cancer after gynecologic cancer. Ann Intern
Med. 131:189–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sverrisson I, Folkvaljon F, Chabok A,
Stattin P, Smedh K and Nikberg M: Anastomotic leakage after
anterior resection in patients with rectal cancer previously
irradiated for prostate cancer. Eur J Surg Oncol. 45:341–346. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guandalino M, Dupré A, François M, Leroy
B, Antomarchi O, Buc E, Dubois A, Guy L, Pezet D and Gagnière J:
Previous radiation for prostate neoplasm alters surgical and
oncologic outcomes after rectal cancer surgery. J Surg Oncol.
112:802–808. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lakkis Z, Vernerey D, Mege D, Faucheron
JL, Panis Y, Tuech JJ, Lefevre JH, Brouquet A, Dumont F, Borg C, et
al: Morbidity and oncological outcomes of rectal cancer impaired by
previous prostate malignancy. Br J Surg. 106:1087–1098. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Buscail E, Blondeau V, Adam JP, Pontallier
A, Laurent C, Rullier E and Denost Q: Surgery for rectal cancer
after high-dose radiotherapy for prostate cancer: Is sphincter
preservation relevant? Colorectal Dis. 17:973–979. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kavanagh DO, Quinlan DM, Armstrong JG,
Hyland JM, O'Connell PR and Winter DC: Management of synchronous
rectal and prostate cancer. Int J Colorectal Dis. 27:1501–1508.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin C, Jin K, Hua H, Lin J, Zheng S and
Teng L: Synchronous primary carcinomas of the rectum and prostate:
Report of three cases. Oncol Lett. 2:817–819. 2011.PubMed/NCBI
|
|
24
|
Edge S: AJCC Cancer Staging Manual.
Springer; New York, NY: 2010
|
|
25
|
US Department of Health and Human
Services, . National Institutes of Health National Cancer
Institute. Common Terminology Criteria for Adverse Events (CTCAE).
version 4.03. 2010
|
|
26
|
Epstein JI, Egevad L, Amin MB, Delahunt B,
Srigley JR and Humphrey PA; Grading Committee, : The 2014
International society of urological pathology (ISUP) consensus
conference on gleason grading of prostatic carcinoma: Definition of
grading patterns and proposal for a new grading system. Am J Surg
Pathol. 40:244–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagtegaal ID and Glynne-Jones R: How to
measure tumour response in rectal cancer? An explanation of
discrepancies and suggestions for improvement. Cancer Treat Rev.
84:1019642020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase III trial after a median follow-up
of 11 years. J Clin Oncol. 30:1926–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Owens CL, Epstein JI and Netto GJ:
Distinguishing prostatic from colorectal adenocarcinoma on biopsy
samples: The role of morphology and immunohistochemistry. Arch
Pathol Lab Med. 131:599–603. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berrington de Gonzalez A, Wong J,
Kleinerman R, Kim C, Morton L and Bekelman JE: Risk of second
cancers according to radiation therapy technique and modality in
prostate cancer survivors. Int J Radiat Oncol Biol Phys.
91:295–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
